[UPDATE: As of July 24, 2019, there have been 9 deaths in the United States attributed to BIA-ALCL]
You may have seen or read recent reports of a type of cancer associated with breast implants. This page is to provide you with the facts, as they are understood right now, of this extremely rare complication. As more is known, we will update this page but as always we welcome phone calls and/or office visits to discuss this relatively complex issue.
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) was first recognized around 2010-2011. The total number of reported cases is still less than 400 worldwide and that number is uncertain since there are dual reports of cases counted from different databases. The number probably will go up over time but may actually go down as the double counted cases are eliminated.
The American Society of Plastic Surgeons and the implant manufacturers Mentor, Allergan and Sientra have all been tracking this disease since it was first identified and have extensive information on all of the reported cases.
Summary of Knowledge May 2017
Plastic Surgery Center of Tulsa Facts:
Additional updated information on BIA-ALCL from the FDA can be found at this links:
The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Safety Communication